Clover Health Investments Corp
$ 4.76
2.15%
07 Aug - close price
- Market Cap 2,507,017,000 USD
- Current Price $ 4.76
- High / Low $ 4.92 / 4.62
- Stock P/E N/A
- Book Value 0.65
- EPS -0.05
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE -0.05 %
- 52 Week High 5.59
- 52 Week Low 1.58
About
Clover Health Investments, Corp. The company is headquartered in Franklin, Tennessee.
Analyst Target Price
$5.17
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-05 | 2026-05-06 | 2026-02-26 | 2025-11-04 | 2025-08-05 | 2025-05-06 | 2025-02-27 | 2024-11-06 | 2024-08-05 | 2024-05-07 | 2024-03-12 | 2023-11-06 |
| Reported EPS | 0.06 | 0.07 | -0.1 | -0.05 | 0.03 | 0.05 | -0.05 | -0.02 | 0.02 | -0.05 | -0.14 | -0.08 |
| Estimated EPS | 0.05 | 0.07 | -0.11 | 0.02 | 0.03 | -0.07 | -0.065 | -0.03 | -0.04 | -0.08 | -0.14 | -0.11 |
| Surprise | 0.01 | 0 | 0.01 | -0.07 | 0 | 0.12 | 0.015 | 0.01 | 0.06 | 0.03 | 0 | 0.03 |
| Surprise Percentage | 20% | 0% | 9.0909% | -350% | 0% | 171.4286% | 23.0769% | 33.3333% | 150% | 37.5% | 0% | 27.2727% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CLOV
2026-07-25 15:39:56
Clover Health Investments Corp. (MUN:7QD) generated €1.64 billion in revenue last year, primarily from its Insurance segment. All of this revenue, €1.64 billion, originated from the United States, indicating the company's strong focus on the US market in the life and health insurance sector.
2026-07-24 19:11:12
Shamis & Gentile P.A. is investigating a data breach involving Clover Health Investments, Corp. dba Clover Health. The breach, which was detected on July 8, 2020, and disclosed to the SEC on July 4, 2026, exposed sensitive personally identifiable and protected health information. Individuals affected by the breach may be entitled to compensation and are encouraged to submit a claim for review.
2026-07-24 02:11:12
Clover Health Investments Corp. Class A (A2QJXX) generated 1.64 billion EUR in revenue last year, primarily from its Insurance segment. This represents an increase from 1.32 billion EUR in the previous year. The entire revenue was generated in the United States.
2026-07-21 20:10:58
Clover Health's Medicare Advantage CEO, Jamie L. Reynoso, sold 4,839 shares of CLOV stock for $21,920, at a weighted average price of $4.53 per share, according to a Rule 10b5-1 trading plan. This transaction occurred after Clover Health shares surged 73% in six months, and the company recently reported mixed Q1 2026 earnings but had its Medicare star rating upgraded to 4.5 stars. Despite the stock appearing slightly overvalued, Reynoso still holds over 2.8 million shares.
2026-07-18 03:10:49
Jamie L. Reynoso, CEO of Clover Health Medicare Advantage, sold 4,839 Class A common shares on July 17, 2026, for a total of $21,920.67 at a price of $4.53 per share. Following this transaction, Reynoso's direct stake in Clover Health fell to 2.81 million shares. This information was generated by AI from an original filing by Clover Health Investments Corp. with the SEC.
2026-07-17 22:10:38
Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. (CLOV), sold 4,839 shares of Class A Common Stock on July 17, 2026. The shares were sold at a weighted average price of $4.53 per share, ranging from $4.35 to $4.63, as part of a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026. Following this transaction, Reynoso directly holds 2,814,640 shares of CLOV.
